Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH MEDIA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Blocking Nerve Growth Factor Receptor Enables Human Nervous System Regeneration

By BiotechDaily International staff writers
Posted on 20 Aug 2014
Image: The presence of p45 (green staining) and p75 (red staining) indicates that motor neurons increase both p45 and p75 expression after sciatic nerve injury in an animal (Photo courtesy of the Salk Institute for Biological Studies).
Image: The presence of p45 (green staining) and p75 (red staining) indicates that motor neurons increase both p45 and p75 expression after sciatic nerve injury in an animal (Photo courtesy of the Salk Institute for Biological Studies).
The mystery of why the human nervous system is unable to regenerate may have been at least partially solved with the identification of a protein called p75 that seems to block the repair of damaged nerve cells.

Investigators at the Salk Institute for Biological Studies (La Jolla, CA, USA) explained that the p75 neurotrophin receptor, a member of the tumor necrosis factor receptor superfamily, was required as a co-receptor for the Nogo receptor (NgR - reticulon 4 receptor) to mediate the activity of regeneration inhibitors such as Nogo. The Nogo receptor mediates axonal growth inhibition and may play a role in regulating axonal regeneration and plasticity in the adult central nervous system.

p75, also called nerve growth factor receptor, contains an extracellular domain containing four 40-amino acid repeats with six cysteine residues at conserved positions followed by a serine/threonine-rich region, a single transmembrane domain, and a 155-amino acid cytoplasmic domain. The cysteine-rich region contains the nerve growth factor binding domain.

In the current study, the investigators used a protein, p45, known to stimulate nervous system regeneration in lower animals but lacking in humans. They found that when added to cultures of human neurons, p45 markedly interfered with the function of p75 as a co-receptor for NgR. p45 bound p75 through both its transmembrane (TM) domain and death domain (DD).

To understand the underlying mechanisms, they determined the three-dimensional NMR solution structure of the intracellular domain of p45 and characterized its interaction with p75. They identified the residues involved in this interaction by NMR and co-immunoprecipitation.

Results of these structural and functional studies published in the August 5, 2014, online edition of the journal PLOS Biology revealed that p45 bound specifically to conserved regions in the p75 transmembrane domain and in the intracellular domain and that this binding blocked p75 dimerization along with its downstream signaling. Blocking the activity of p75 allowed nervous tissue to regenerate.

“This research implies that we might be able to mimic neuronal repair processes that occur naturally in lower animals, which would be very exciting,” said senior author Dr. Kuo-Fen Lee, professor of molecular neurobiology at the Salk Institute for Biological Studies. “We do not know why this nerve regeneration does not occur in humans. We can speculate that the brain has so many neural connections that this regeneration is not absolutely necessary.”

Related Links:

Salk Institute for Biological Studies



Channels

Biochemistry

view channel

Possible New Target Found for Treating Brain Inflammation

Scientists have identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited eurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that suppress this enzyme.... Read more

Therapeutics

view channel
Image: Cancer cells infected with tumor-targeted oncolytic virus (red). Green indicates alpha-tubulin, a cell skeleton protein. Blue is DNA in the cancer cell nuclei (Photo courtesy of Dr. Rathi Gangeswaran, Bart’s Cancer Institute).

Innovative “Viro-Immunotherapy” Designed to Kill Breast Cancer Cells

A leading scientist has devised a new treatment that employs viruses to kill breast cancer cells. The research could lead to a promising “viro-immunotherapy” for patients with triple-negative breast cancer,... Read more

Lab Technologies

view channel
Image: MIT researchers have designed a microfluidic device that allows them to precisely trap pairs of cells (one red, one green) and observe how they interact over time (Photo courtesy of Burak Dura, MIT).

New Device Designed to See Communication between Immune Cells

The immune system is a complicated network of many different cells working together to defend against invaders. Effectively combating an infection depends on the interactions between these cells.... Read more

Business

view channel

Program Designed to Provide High-Performance Computing Cluster Systems for Bioinformatics Research

Dedicated Computing (Waukesha, WI, USA), a global technology company, reported that it will be participating in the Intel Cluster Ready program to deliver integrated high-performance computing cluster solutions to the life sciences market. Powered by Intel Xeon processors, Dedicated Computing is providing a range of... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.